TB PRACTECAL: launch event
In Nukus, Karakalpakstan, in the west of Uzbekistan, we treat patients for tuberculosis (TB) under the PRACTECAL clinical trial.

The trial combines the first new TB drugs available in over 50 years with existing drugs to treat drug-resistant forms of the disease. Uzbekistan is among the top 27 countries with the highest rates of multidrug-resistant TB (MDR-TB).

We also treat children with TB with a shorter regimen of nine months, instead of the usual 12 months or more, and is conducting research into the results.

In the capital, Tashkent, we support the regional AIDS centre, with the aim of increasing access to diagnosis and care for patients living with HIV and treating co-infections.

We are currently responding to the coronavirus COVID-19 pandemic in the country.

In 2019

You can see tuberculosis in Uzbekistan in a heartbeat

Project Update 24 Sep 2010

MSF assists victims of violence in Kyrgyzstan and Uzbekistan

Project Update 16 Jun 2010

TB care in Uzbekistan

Project Update 24 Mar 2008

Pilot project to prove that disease can be treated in poor countries.

Press Release 29 Oct 2003

Time to prioritise tuberculosis laboratory services

Project Update 1 Oct 2003

Thin Girl with a Headscarf

Project Update 1 Aug 2003